Recent Advances in Cancer Immunotherapy Delivery Modalities

被引:12
|
作者
Muthukutty, Palaniyandi [1 ]
Woo, Hyun Young [2 ,3 ]
Ragothaman, Murali [1 ]
Yoo, So Young [1 ]
机构
[1] Pusan Natl Univ, BIOIT Foundry Technol Inst, Busan 46241, South Korea
[2] Pusan Natl Univ Hosp, Dept Internal Med, Busan 49241, South Korea
[3] Pusan Natl Univ Hosp, Med Res Inst, Busan 49241, South Korea
关键词
drug delivery; cancer immunotherapy; CAR-T cells; nanoparticles; INJECTABLE POLYPEPTIDE HYDROGEL; COLONY-STIMULATING FACTOR; ONCOLYTIC VACCINIA VIRUS; MODIFIED T-CELLS; DRUG-DELIVERY; CO-DELIVERY; ANTITUMOR IMMUNITY; TUMOR-GROWTH; PHASE-II; IN-VIVO;
D O I
10.3390/pharmaceutics15020504
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Immunotherapy is crucial in fighting cancer and achieving successful remission. Many novel strategies have recently developed, but there are still some obstacles to overcome before we can effectively attack the cancer cells and decimate the cancer environment by inducing a cascade of immune responses. To successfully demonstrate antitumor activity, immune cells must be delivered to cancer cells and exposed to the immune system. Such cutting-edge technology necessitates meticulously designed delivery methods with no loss or superior homing onto cancer environments, as well as high therapeutic efficacy and fewer adverse events. In this paper, we discuss recent advances in cancer immunotherapy delivery techniques, as well as their future prospects.
引用
收藏
页数:24
相关论文
共 50 条
  • [1] Delivery strategies of cancer immunotherapy: recent advances and future perspectives
    Zhao, Zhongwei
    Zheng, Liyun
    Chen, Weiqian
    Weng, Wei
    Song, Jingjing
    Ji, Jiansong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2019, 12 (01)
  • [2] Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy
    Yu, Albert
    Dai, Xiaoyong
    Wang, Zixian
    Chen, Huaqing
    Guo, Bing
    Huang, Laiqiang
    BIOSENSORS-BASEL, 2022, 12 (02):
  • [3] Targeting lymph node delivery with nanovaccines for cancer immunotherapy: recent advances and future directions
    Li, Yueyi
    Li, Shen
    Jiang, Zedong
    Tan, Keqin
    Meng, Yuanling
    Zhang, Dingyi
    Ma, Xuelei
    JOURNAL OF NANOBIOTECHNOLOGY, 2023, 21 (01)
  • [4] Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy
    Li, Su-Ran
    Huo, Fang-Yi
    Wang, Han-Qi
    Wang, Jing
    Xu, Chun
    Liu, Bing
    Bu, Lin-Lin
    JOURNAL OF NANOBIOTECHNOLOGY, 2022, 20 (01)
  • [5] Recent advances in overcoming barriers to cell-based delivery systems for cancer immunotherapy
    Ding, Yingyue
    Wang, Yixin
    Hu, Quanyin
    EXPLORATION, 2022, 2 (03):
  • [6] Recent advances in applying nanotechnologies for cancer immunotherapy
    Mahjub, Reza
    Jatana, Sukhdeep
    Lee, Suen Ern
    Qin, Zhu
    Pauli, Griffin
    Soleimani, Meysam
    Madadi, Soheil
    Li, Shyh-Dar
    JOURNAL OF CONTROLLED RELEASE, 2018, 288 : 239 - 263
  • [7] Mesoporous Silica Nanoparticles as an Ideal Platform for Cancer Immunotherapy: Recent Advances and Future Directions.
    Godakhindi, Varsha
    Tarannum, Mubin
    Dam, Sudip Kumar
    Vivero-Escoto, Juan L.
    ADVANCED HEALTHCARE MATERIALS, 2024, 13 (20)
  • [8] Recent Advances in Anti-cancer Protein/Peptide Delivery
    Liu, Xun
    Wu, Fan
    Ji, Yong
    Yin, Lichen
    BIOCONJUGATE CHEMISTRY, 2019, 30 (02) : 305 - 324
  • [9] Recent Advances in siRNA Delivery Systems for Prostate Cancer Therapy
    Aghamiri, Shahin
    Raee, Pourya
    Shahmohamadnejad, Shiva
    Shabani, Sasan
    Ghorbani, Jaber
    Sameni, Marzieh
    Ebrahimi, Mohammad Taha
    CURRENT PHARMACEUTICAL BIOTECHNOLOGY, 2022, 23 (04) : 579 - 593
  • [10] Recent advances in nanoformulation-based delivery for cancer immunotherapy
    Bokhari, Seyedeh Saimeh
    Ali, Tayyab
    Naeem, Muhammad
    Hussain, Fatma
    Nasir, Abdul
    NANOMEDICINE, 2024, 19 (14) : 1253 - 1269